DiscoverResearch To Practice | Oncology Videos
Research To Practice | Oncology Videos
Claim Ownership

Research To Practice | Oncology Videos

Author: Dr Neil Love

Subscribed: 575Played: 46,067
Share

Description

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
1057 Episodes
Reverse
Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics: Introduction (0:00) Prologue: Saturday Night Fever (1:35) Baby Boomers' Guide to Mechanisms of Action (3:07) Second-Line Treatment (12:36) Complications Associated with Bispecific Antibodies (23:41) Case Presentations (25:52) New Bispecific T-Cell Engagers — Surovatamig (26:24) Other Novel Agents (50:05) CME information and select publications
Where We Are, Where We're Headed: Bispecific Antibodies in the Management of Follicular Lymphoma | Faculty Presentation 2: Emerging Bispecific Antibody Strategies for Follicular Lymphoma — Dr Matasar CME information and select publications
Where We Are, Where We're Headed: Bispecific Antibodies in the Management of Follicular Lymphoma | Faculty Presentation 1: Current Use of Bispecific Antibodies for Relapsed/Refractory Follicular Lymphoma  — Prof Cheah CME information and select publications
Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics: Multiple Myeloma (0:00) Introduction: ESMO 2026; Recent FDA Approvals (1:53) Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46) Bispecific Antibodies — Dr Lonial (19:16) Antibody-Drug Conjugates — Dr Richardson (37:08) Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10) CME information and select publications
Featuring perspectives from Dr Neeraj Agarwal and Dr Emmanuel S Antonarakis, including the following topics: Introduction: ESMO 2026; Recent FDA Approvals (0:00) Selection of Endocrine Therapy — Dr Antonarakis (2:24) Utility of PARP Inhibitors — Dr Agarwal (22:59) AKT Inhibition for PTEN-Deficient Disease — Dr Antonarakis (35:42) Radiopharmaceuticals — Dr Agarwal (45:02) CME information and select publications
loading
Comments